FDG-PET and cMRI for the differential diagnosis of parkinson's disease and atypical parkinson syndroms

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016574

Enrollment

314

Registered

2019-01-28

Start date

2018-12-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G23.2 G23.1 G23.9 G20

Interventions

Group 1: Every Patient under the differential diagnosis of an atypical parkinson syndrom recieves in the process of clinical diagnostics a FDG-PET and a MRI of the brain as well as a clicincal diagnos

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presentation of an atypical parkinson syndrom in one of the study centers - Symptoms / anamnesis suggestive for an atypical parkinson syndrom - age > 18 years - the patient has recieved an MRI and a FDG-PET of the brain

Exclusion criteria

Exclusion criteria: No possibility for oral and written consent

Design outcomes

Primary

Measure	Time frame
The diagnostic accuracy of the MRI and the FDG-PET in the diseases mentioned above (ICD-10). (Measured in sensitivity and specifity, comparison of FDG-PET and MRI by receiver operating characteristics (ROC)-Analysis)	—

Secondary

Measure	Time frame
- Evaluation of a potential synergistic value of both imaging modalities - Correlation of the imaging findings with clinical parameters	—

Countries

Germany

Contacts

Public ContactNils Schröter

Klinik für NeurologieUniversitätsklinikum Freiburg

nils.schroeter@uniklinik-freiburg.de0761-270-50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026